22 Jul 2014 Bill Ackman: Will not raise offer for Allergan ( Portfolio )

Bill Ackman, Pershing Square, explains why he is not upping his bid for Allergan. The market clearly thinks the chance of Valeant buying Allergan has gone up, says Ackman.